Denis Gravel
15Patents
9h-index
19Co-inventors
65Inventor score
Filing activity: Sep 9, 1994 → Jan 28, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6762160B2 | Composition for removing biofilms comprising a detergent and a salt forming acid | Human Necessities | 35 | Expired |
| US7105539B2 | Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex | Chemistry; Metallurgy | 20 | Expired |
| US7365091B2 | Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX | Chemistry; Metallurgy | 20 | Expired |
| US6020311A | GRF analogs with increased biological potency | Human Necessities | 19 | Expired |
| US6458764B1 | GRF analogs with increased biological potency | Emerging Cross-Sectional Technologies | 18 | Expired |
| US6194384A | Long-acting galenical formulation for GRF peptides | Human Necessities | 15 | Expired |
| US7316997B2 | GH secretagogues and uses thereof | Chemistry; Metallurgy | 15 | Expired |
| US8435945B2 | GH secretagogues and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US8314066B2 | GH secretagogues and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US8383672B2 | Halogenated rhodamine derivatives and applications thereof | Emerging Cross-Sectional Technologies | 9 | Active |
| US7560574B2 | Halogenated rhodamine derivatives and applications thereof | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7067488B2 | Modified GLP-1 peptides with increased biological potency | Human Necessities | 4 | Expired |
| US8481489B2 | GH secretagogues and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US9636363B2 | Halogenated rhodamine derivatives and applications thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US5580867A | Myocardial protection during ischemia and reperfusion | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.